| Aetna | Botulinum Toxin | 2026-02-09 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Myoelectric Prosthetic Components for the Upper Limb | 2026-02-09 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Urological Supplies | 2026-02-09 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Lymphoscintigraphy | 2026-02-09 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Transcranial Magnetic Stimulation | 2026-02-09 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Enzyme Replacement Therapies | 2026-02-09 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Infliximab and Infliximab Biosimilars | 2026-02-09 |
| BCBS Highmark Penn Medicare Advantage | Denosumab (Prolia, Xgeva) and Denosumab Biosimilars | 2026-02-09 |
| BCBS Highmark Penn Medicare Advantage | Monoclonal Antibodies for the Treatment of Eosinophilic Conditions | 2026-02-09 |
| BCBS Highmark Penn Medicare Advantage | Granulocyte Colony-Stimulating Factors | 2026-02-09 |